Nasdaq: DMAC
DiaMedica Therapeutics insiders
The officers, directors and 10% owners of DiaMedica Therapeutics Inc. who hold the most stock, valued at the live DMAC price.
$8.02
DMAC today −$570K (−6.64%)
Market closed. Prices as of Nov 19, 4:04 PM ET
- Ranked insiders
- 6
- Their DMAC stock
- $362M
- Market value
- $463M
- Held by ranked insiders
- 78.0%
Insiders by value of DMAC holdings
SEC ownership page| # | Insider | Role | Shares | Value | Of company | Overall rank |
|---|---|---|---|---|---|---|
| 1 | Jan Stahlberg | 10% owner | 14,528,930 | $117M | 25.1% | 1349th |
| 2 | Ab Trill | 10% owner | 8,825,742 | $70.8M | 15.3% | 1971st |
| 3 | Thomas Von Koch | 10% owner | 8,383,577 | $67.2M | 14.5% | 2057th |
| 4 | Private Ab TomEnterprise | 10% owner | 5,526,435 | $44.3M | 9.56% | 2772nd |
| 5 | Richard Jacinto II | 10% owner | 4,958,823 | $39.8M | 8.58% | 3032nd |
| 6 | Ab TomEnterprise | 10% owner | 2,855,827 | $22.9M | 4.94% | 4683rd |
Only insiders worth at least $5 million in listed stock are ranked. Holdings come from each insider's latest Form 3, 4 or 5 for DiaMedica Therapeutics; see each profile for the filing.